Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

LANNETT CO INC

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 36
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 37
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Sept. 24, 2024, 08:51 UTC
  • 29
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

MSN

  • FDA Approval
  • Sept. 24, 2024, 04:22 UTC
  • 39
  • 0 comments

FDA approve CLOPIDOGREL BISULFATE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • Sept. 23, 2024, 18:08 UTC
  • 47
  • 0 comments

FDA approve EPHEDRINE SULFATE

Comment Full text

TORRENT PHARMS LTD

  • FDA Approval
  • Sept. 23, 2024, 15:01 UTC
  • 41
  • 0 comments

FDA approve DAPAGLIFLOZIN;SAXAGLIPTIN

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 35
  • 0 comments

FDA approve CIPROFLOXACIN

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 36
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 33
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

SANOFI

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 30
  • 0 comments

FDA approve FEXINIDAZOLE

Comment Full text
  • Previous
  • 304
  • 305
  • 306
  • 307
  • 308
  • Next

Search

News categories

  • Technical Exchange News(10609)
  • Event(2025)
  • SEC News(185003)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122517)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin